Thibault, Patricia A
$150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2016-2017
États-Unis
"Kill-switch" enabled, immune-silent, non-cytopathic, and persistent paramyxovirus vector for respiratory gene therapy.